Employers Holdings Inc. acquired a new stake in shares of Clorox Co (NYSE:CLX) in the second quarter, HoldingsChannel.com reports. The institutional investor acquired 700 shares of the company’s stock, valued at approximately $107,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of CLX. Comerica Bank increased its position in Clorox by 1.2% during the 2nd quarter. Comerica Bank now owns 32,346 shares of the company’s stock worth $5,162,000 after purchasing an additional 396 shares in the last quarter. Envestnet Asset Management Inc. grew its position in Clorox by 1.9% in the second quarter. Envestnet Asset Management Inc. now owns 148,688 shares of the company’s stock valued at $22,766,000 after acquiring an additional 2,812 shares in the last quarter. Boys Arnold & Co. Inc. grew its position in Clorox by 1.6% in the second quarter. Boys Arnold & Co. Inc. now owns 9,500 shares of the company’s stock valued at $1,455,000 after acquiring an additional 151 shares in the last quarter. Executive Wealth Management LLC grew its position in Clorox by 14.2% in the second quarter. Executive Wealth Management LLC now owns 23,014 shares of the company’s stock valued at $3,524,000 after acquiring an additional 2,867 shares in the last quarter. Finally, Amica Retiree Medical Trust acquired a new stake in Clorox in the second quarter valued at approximately $90,000. 77.01% of the stock is owned by institutional investors.

In related news, Director A D. David Mackay sold 3,400 shares of the firm’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $154.87, for a total transaction of $526,558.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Denise Garner sold 20,399 shares of the firm’s stock in a transaction on Friday, June 7th. The stock was sold at an average price of $157.61, for a total value of $3,215,086.39. Following the transaction, the senior vice president now owns 4,896 shares in the company, valued at $771,658.56. The disclosure for this sale can be found here. Insiders have sold 25,786 shares of company stock worth $4,054,776 over the last 90 days. 1.40% of the stock is currently owned by company insiders.

Several analysts have issued reports on the stock. Argus downgraded shares of Clorox from a “buy” rating to a “hold” rating in a research report on Monday, May 20th. BMO Capital Markets set a $168.00 price objective on shares of Clorox and gave the company a “buy” rating in a research report on Thursday, May 2nd. Bank of America reaffirmed a “neutral” rating and issued a $154.00 price objective (down previously from $165.00) on shares of Clorox in a research report on Thursday, May 2nd. UBS Group increased their price objective on shares of Clorox from $110.00 to $128.00 and gave the company a “sell” rating in a research report on Friday, August 2nd. Finally, Citigroup set a $156.00 price objective on shares of Clorox and gave the company a “hold” rating in a research report on Thursday, May 23rd. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company’s stock. Clorox has a consensus rating of “Hold” and an average target price of $154.07.

Shares of Clorox stock traded up $1.95 on Friday, hitting $160.90. 742,500 shares of the company’s stock traded hands, compared to its average volume of 1,086,078. The stock has a market cap of $20.03 billion, a P/E ratio of 25.46, a PEG ratio of 4.95 and a beta of 0.37. The company has a quick ratio of 0.55, a current ratio of 0.91 and a debt-to-equity ratio of 4.09. The firm’s 50-day moving average is $158.74 and its 200 day moving average is $155.63. Clorox Co has a 52-week low of $141.53 and a 52-week high of $167.70.

Clorox (NYSE:CLX) last released its earnings results on Thursday, August 1st. The company reported $1.88 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.84 by $0.04. The company had revenue of $1.63 billion during the quarter, compared to analysts’ expectations of $1.69 billion. Clorox had a return on equity of 118.88% and a net margin of 13.20%. The business’s revenue was down 3.8% on a year-over-year basis. During the same period in the prior year, the business posted $1.66 EPS. Equities research analysts forecast that Clorox Co will post 6.4 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 16th. Investors of record on Wednesday, July 31st were paid a dividend of $1.06 per share. The ex-dividend date was Tuesday, July 30th. This is a boost from Clorox’s previous quarterly dividend of $0.96. This represents a $4.24 annualized dividend and a yield of 2.64%. Clorox’s dividend payout ratio (DPR) is 67.09%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Read More: How to Invest in Marijuana Stocks

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.